Genotyping Assay Market Size Forecast: How The Industry Is Expected To Grow From 2026 To 2030

Genotyping Assay Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Genotyping Assay Market Value Growth And Long-Term Outlook

The genotyping assay market size has experienced substantial expansion in recent years. It is projected to climb from $41.31 billion in 2025 to $50.86 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 23.1%. The increase observed historically is attributable to elements such as the advancement of PCR techniques, the expansion of molecular diagnostics, requirements for pharmaceutical safety testing, the initial commercialization of assays, and the impetus from academic research.

The genotyping assay market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $116.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.9%. This growth during the forecast period is primarily driven by factors such as a rise in biomarker-driven drug development, enhanced laboratory automation, wider adoption of companion diagnostics, the need for rapid assays, and regulatory validation. Key trends expected over the forecast period encompass a growing preference for SNP-based assays, a higher uptake of PCR-based genotyping, the development of high-sensitivity genotyping assays, increased use of genotyping assays in drug development, and the incorporation of automation into assay processing.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=99877717&type=smp&name=Genotyping%20Assay%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Genotyping Assay Market Growth Drivers: What’s Behind The Acceleration?

The future expansion of the genotyping assay market is anticipated to be propelled by the rising occurrence of genetic disorders. These medical conditions stem from abnormalities or mutations in an individual’s deoxyribonucleic acid (DNA). Genotyping assays work by comparing the DNA of affected individuals to that of healthy individuals to detect changes, thereby revealing specific genetic mutations or variations linked to a particular genetic disorder. For instance, in June 2023, Gene People, a UK-based registered charity organization dedicated to supporting individuals with genetic conditions, reported that one in every 25 children in the UK had a genetic disorder, impacting approximately 30,000 newborns and young children in the country, alongside more than 2.4 million children and adults annually. Consequently, the increasing prevalence of genetic disorders is a key factor driving the growth of the genotyping assay market.

Genotyping Assay Market Segment Analysis Spotlighting Growth Areas

The genotyping assay market covered in this report is segmented –

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics

2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies

3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits

2) By Genotyping Services: Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services

3) By Instruments: PCR Machines, Sequencing Instruments, Microarrays

4) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

Genotyping Assay Market Trends Redefining Industry Growth

Companies operating in the genotyping assay market are making significant strides in genomic research, notably by developing CE-IVD marked assays for detecting treatment-resistant strains of HIV-1. An example is the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay designed to analyze positive human immunodeficiency virus (HIV) samples and identify genetic variants that may exhibit resistance to common antiretroviral treatments. Thermo Fisher Scientific, a US-based company, introduced this kit in January 2023. This system is capable of identifying treatment-resistant HIV-1 strains and offers distinct features such as the evaluation of genomic mutations, utilization of HIV RNA, detection of drug resistance mutations, application of gold-standard Sanger sequencing technology, and its suitability for clinical applications. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has enhanced capabilities by improving the identification of treatment-resistant HIV-1 strains, offering pre-prepared reagents and controls, adhering to regulatory standards, demonstrating strong performance, and ensuring compatibility with current sequencing platforms and laboratory procedures.

Genotyping Assay Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the genotyping assay market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs

View The Full Genotyping Assay Market Report:

https://thebusinessresearchcompany.com/report/genotyping-assay-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Genotyping Assay Market Regional Split: Which Areas Are Fueling Growth?

North America was the largest region in the genotyping assay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model